ALEO2 Fundamental Analysis - EO2

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to ALEO2. ALEO2 was compared to 69 industry peers in the Oil, Gas & Consumable Fuels industry. While ALEO2 seems to be doing ok healthwise, there are quite some concerns on its profitability. ALEO2 has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALEO2 had negative earnings in the past year.

ALEO2 had a positive operating cash flow in the past year.

Of the past 5 years ALEO2 4 years were profitable.

Of the past 5 years ALEO2 4 years had a positive operating cash flow.

1.2 Ratios

ALEO2 has a worse Return On Assets (-0.23%) than 75.36% of its industry peers.

With a Return On Equity value of -0.46%, ALEO2 is not doing good in the industry: 75.36% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-0.23%
ROE	-0.46%
ROIC	N/A

ROA(3y)3.69%

ROA(5y)2.69%

ROE(3y)8.38%

ROE(5y)6.12%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALEO2 has a better Gross Margin (55.94%) than 68.12% of its industry peers.

In the last couple of years the Gross Margin of ALEO2 has grown nicely.

The Profit Margin and Operating Margin are not available for ALEO2 so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	55.94%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-3.8%

GM growth 5Y19.22%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALEO2 does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, ALEO2 has about the same amount of shares outstanding.

Compared to 5 years ago, ALEO2 has less shares outstanding

ALEO2 has a better debt/assets ratio than last year.

2.2 Solvency

ALEO2 has an Altman-Z score of 1.58. This is a bad value and indicates that ALEO2 is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of 1.58, ALEO2 is in line with its industry, outperforming 42.03% of the companies in the same industry.

ALEO2 has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.

ALEO2 has a Debt to Equity ratio of 0.36. This is in the better half of the industry: ALEO2 outperforms 62.32% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.36
Debt/FCF	N/A
Altman-Z	1.58

ROIC/WACCN/A

WACC5.95%

2.3 Liquidity

A Current Ratio of 2.17 indicates that ALEO2 has no problem at all paying its short term obligations.

The Current ratio of ALEO2 (2.17) is better than 82.61% of its industry peers.

ALEO2 has a Quick Ratio of 1.49. This is a normal value and indicates that ALEO2 is financially healthy and should not expect problems in meeting its short term obligations.

The Quick ratio of ALEO2 (1.49) is better than 75.36% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.17
Quick Ratio	1.49

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for ALEO2 have decreased strongly by -127.07% in the last year.

ALEO2 shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.49%.

Measured over the past years, ALEO2 shows a small growth in Revenue. The Revenue has been growing by 4.28% on average per year.

EPS 1Y (TTM)-127.07%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-159.96%

Revenue 1Y (TTM)-11.49%

Revenue growth 3Y-0.53%

Revenue growth 5Y4.28%

Sales Q2Q%-2.44%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALEO2. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ALEO2.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	7.05

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALEO2 does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

EO2

EPA:ALEO2 (12/5/2025, 7:00:00 PM)

2.8

0 (0%)

Chartmill FA Rating

GICS SectorEnergy

GICS IndustryGroupEnergy

GICS IndustryOil, Gas & Consumable Fuels

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners28.33%

Ins Owner ChangeN/A

Market Cap6.72M

Revenue(TTM)30.16M

Net Income(TTM)-93.00K

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.22
P/FCF	N/A
P/OCF	3.62
P/B	0.33
P/tB	0.36
EV/EBITDA	7.05

EPS(TTM)-0.08

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.38

FCFYN/A

OCF(TTM)0.77

OCFY27.59%

SpS12.57

BVpS8.41

TBVpS7.72

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-0.23%
ROE	-0.46%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	55.94%
FCFM	N/A

ROA(3y)3.69%

ROA(5y)2.69%

ROE(3y)8.38%

ROE(5y)6.12%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-3.8%

GM growth 5Y19.22%

F-Score5

Asset Turnover0.76

Health

		Industry Rank	Sector Rank
Debt/Equity	0.36
Debt/FCF	N/A
Debt/EBITDA	3.66
Cap/Depr	79.15%
Cap/Sales	9.19%
Interest Coverage	N/A
Cash Conversion	92.89%
Profit Quality	N/A
Current Ratio	2.17
Quick Ratio	1.49
Altman-Z	1.58

F-Score5

WACC5.95%

ROIC/WACCN/A

Cap/Depr(3y)115.4%

Cap/Depr(5y)96.64%

Cap/Sales(3y)8.27%

Cap/Sales(5y)6.82%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-127.07%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-159.96%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-11.49%

Revenue growth 3Y-0.53%

Revenue growth 5Y4.28%

Sales Q2Q%-2.44%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-472.52%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y86.46%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y170.07%

OCF growth 3Y-29.12%

OCF growth 5Y-11.3%

EO2 / ALEO2.PA FAQ

What is the ChartMill fundamental rating of EO2 (ALEO2.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALEO2.PA.

What is the valuation status for ALEO2 stock?

ChartMill assigns a valuation rating of 0 / 10 to EO2 (ALEO2.PA). This can be considered as Overvalued.

Can you provide the profitability details for EO2?

EO2 (ALEO2.PA) has a profitability rating of 2 / 10.

EO2 (ALEO2.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

EO2 / ALEO2.PA FAQ

What is the ChartMill fundamental rating of EO2 (ALEO2.PA) stock?

What is the valuation status for ALEO2 stock?

Can you provide the profitability details for EO2?